Taxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Taxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinoma

Published:2005-01-06 Issue:4 Volume:103 Page:672-679
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Bria Emilio,Giannarelli Diana,Felici Alessandra,Peters William P.,Nisticò Cecilia,Vanni Barbara,Cuppone Federica,Cognetti Francesco,Terzoli Edmondo

Funder

National Service of Health (Italy)

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference19 articles.

1. Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women;Fossati;J Clin Oncol.,1998

2. Sequential single-agent chemotherapy for metastatic breast cancer: therapeutic nihilism or realism?;Seidman;J Clin Oncol.,2003

3. Overall survival is not a realistic end-point for clinical trials of new drugs in advanced solid tumors: a critical assessment based on recently reported Phase III trials in colorectal and breast cancer;Di Leo;J Clin Oncol.,2003

4. National Cancer Institute http://www.cancer.gov 2004

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifactorial drug carrier system bringing both chemical and physical therapeutics to the treatment of tumor heterogeneity;Journal of Controlled Release;2024-05

2. Nanomedicine-Based Combinational Therapy for Breast Cancer;Hormone Related Cancer Mechanistic and Nanomedicines;2022

3. Nanotechnology as a Promising Strategy for Anticancer Drug Delivery;Current Drug Delivery;2018-04-16

4. Co-delivery of docetaxel and doxorubicin using biodegradable PEG-PLA micelles for treatment of breast cancer with synergistic anti-tumour effects;Journal of Macromolecular Science, Part A;2018-01-23

5. Victims of Our Own Success: Cardiac Toxicities from Conventional and Emerging Cancer Therapies;The MASCC Textbook of Cancer Supportive Care and Survivorship;2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3